Translational Development Acquisition Corp. (NASDAQ:TDACU) Short Interest Update

Translational Development Acquisition Corp. (NASDAQ:TDACU) saw a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 6 shares, a growth of 100.0% from the August 15th total of 3 shares. Based on an average daily volume of 20 shares, the days-to-cover ratio is currently 0.3 days.

Translational Development Acquisition Price Performance

NASDAQ:TDACU opened at $12.24 on Thursday. The stock has a 50 day simple moving average of $12.14 and a 200 day simple moving average of $11.50. Translational Development Acquisition has a 1-year low of $10.71 and a 1-year high of $17.29.

About Translational Development Acquisition

Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.

In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.

Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.